Compare SRBK & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRBK | INMB |
|---|---|---|
| Founded | 1887 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.9M | 34.3M |
| IPO Year | 2023 | 2018 |
| Metric | SRBK | INMB |
|---|---|---|
| Price | $18.54 | $1.38 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.40 |
| AVG Volume (30 Days) | 33.6K | ★ 289.9K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.08% | N/A |
| EPS Growth | ★ 138.36 | 11.85 |
| EPS | ★ 0.20 | N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $92.65 | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $12.30 | $1.09 |
| 52 Week High | $18.75 | $11.64 |
| Indicator | SRBK | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 74.42 | 54.42 |
| Support Level | $16.24 | $1.15 |
| Resistance Level | N/A | $1.48 |
| Average True Range (ATR) | 0.46 | 0.09 |
| MACD | 0.09 | 0.02 |
| Stochastic Oscillator | 87.41 | 65.67 |
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.